Treatment Overview
Filtration MIGS in Korea refers to a category of Minimally Invasive Glaucoma Surgery techniques that create a controlled, low-risk filtration channel to bypass the eye’s natural drainage resistance and lower intraocular pressure (IOP). Unlike traditional glaucoma surgeries (e.g., trabeculectomy), which create a full-thickness drainage opening, Filtration MIGS uses micro-stents, micro-incisions, and precise tissue modulation to establish a regulated outflow pathway while minimizing trauma, scarring, and postoperative complications.
Korean ophthalmology centers combine these filtration-based MIGS procedures with AI-enhanced surgical planning, OCT-guided imaging, micro-stent technology, anti-fibrotic optimization, and digital outflow modeling, resulting in highly effective, predictable, and safer long-term IOP reduction.
Filtration MIGS is ideal for patients needing stronger pressure reduction than trabecular or suprachoroidal MIGS alone.
Purpose & Benefits
Purpose
- Establish a controlled filtration pathway to lower intraocular pressure.
- Provide enhanced outflow for patients with moderate to advanced glaucoma.
- Reduce dependence on medications when trabecular or suprachoroidal MIGS are insufficient.
- Offer a less traumatic alternative to full-thickness filtering surgeries.
Benefits
- Significant IOP Reduction: Stronger pressure lowering compared to angle-based MIGS.
- Minimally Invasive: Small incisions and micro-implants reduce tissue disruption.
- Reduced Complication Rate: Safer than traditional trabeculectomy or tube shunts.
- Long-Term Stability: Designed for durable and consistent pressure control.
- Lower Medication Burden: Many patients reduce multiple glaucoma drops.
- Micro-Stent Technology: Ensures controlled, predictable outflow.
Ideal Candidates
Filtration MIGS in Korea is ideal for:
- Patients with moderate to advanced open-angle glaucoma.
- Individuals who require stronger IOP reduction than standard MIGS provides.
- Patients intolerant to medications or needing multi-level pressure control.
- Individuals with progression despite laser or angle-based MIGS.
- Patients undergoing combined cataract + MIGS surgery.
- Those with healthy conjunctiva and no extensive scarring.
Possible Risks & Complications
Filtration MIGS has a better safety profile than traditional filtering procedures, but mild risks include:
- Transient hypotony (usually mild and short-lived)
- Mild irritation or redness
- Small filtration bleb formation
- Temporary blurred vision
- Rare bleb leakage or fibrosis
Korean surgeons minimize risks using:
- Anti-fibrotic modulation
- OCT-guided implant positioning
- AI-driven flow prediction
- Micro-suturing and tissue-preserving techniques
Types of Filtration MIGS Performed in Korea
Korea offers multiple filtration-based MIGS options tailored to disease severity and anatomy:
1. XEN Gel Stent (Filtered Outflow MIGS)
- Soft gelatin implant creating a controlled channel from the anterior chamber to the subconjunctival space.
- Provides stronger IOP reduction than angle-based MIGS.
2. PreserFlo MicroShunt (Advanced Filtration MIGS)
- A micro-tube device placed beneath the conjunctiva to establish a long-lasting, low-resistance drainage pathway.
- Excellent safety and predictable results.
3. Needle-Assisted Filtration Enhancement (NAFE)
- Micro-needle technique used to optimize the subconjunctival space for better flow.
- Often used with stent-based MIGS.
4. Minimally Invasive Bleb Surgery (MIBS)
- Creates a micro-bleb with incredibly low risk of leakage or scarring.
- Considered a hybrid between standard MIGS and traditional trabeculectomy.
Korean clinics customize the option based on glaucoma severity and anatomical suitability.
Surgical Techniques
AI-Based Surgical Planning
Predicts optimal implant type, placement angle, and outflow resistance.
Subconjunctival Micro-Stent Placement
Creates a low-resistance filtration pathway with minimal tissue disruption.
OCT-Guided Needle Dissection
Ensures precise subconjunctival tunnel creation without excessive manipulation.
Anti-Fibrotic Delivery
Prevents scarring and maintains long-term implant patency.
Minimalist Conjunctival Handling
Reduces inflammation and enhances long-term filtration success.
Treatment Process in Korea
Step-by-Step Workflow
Step 1 – Detailed Glaucoma Assessment
Includes OCT imaging, IOP measurement, gonioscopy, visual fields, and AI flow modeling.
Step 2 – Customized Filtration MIGS Planning
Surgeons choose the appropriate stent, shunt, or bleb technique.
Step 3 – Micro-Incision & Implantation
A tiny entry point is created for stent insertion into the anterior chamber and subconjunctival space.
Step 4 – Flow Establishment
Controlled drainage is confirmed using intracameral visualization and imaging.
Step 5 – Postoperative Monitoring
Follow-up ensures bleb stability, flow quality, and pressure stabilization.
Treatment Duration: 10–20 minutes per eye
Setting: Outpatient or short-stay surgical suite
Recovery & After-Care
After-Care Guidelines
- Use anti-inflammatory and antibiotic drops for 2–4 weeks.
- Avoid eye rubbing, heavy lifting, and water exposure for 1–2 weeks.
- Wear protective eyewear outdoors.
- Attend scheduled follow-up visits.
- Continue or adjust glaucoma medications as directed.
Recovery Timeline
Days 1–3: Mild discomfort or redness.
Week 1: Bleb or filtration site begins stabilizing.
Weeks 2–4: Significant IOP reduction; medication taper may begin.
1–3 Months: Full healing with long-term flow stability.
Results & Longevity
Expected Results
- Strong IOP reduction compared to most other MIGS.
- Consistent long-term pressure control when scarring is minimized.
- Reduced medication dependence.
- Predictable healing and fewer complications than traditional surgery.
Longevity
- Filtration MIGS can provide years to decades of stable pressure reduction.
- Success depends on maintaining bleb health and preventing fibrosis.
- Korean clinics enhance longevity through advanced anti-scarring protocols.
Why Korea Is a Top Destination
- Top-Level MIGS Specialists: Korean surgeons lead in advanced filtration-based MIGS.
- State-of-the-Art Micro-Stent Technology: Latest-generation XEN/PreserFlo platforms.
- AI-Powered Planning: Personalized outflow and flow-resistance modeling.
- Ultra-Precise Imaging: OCT-guided subconjunctival mapping and postoperative monitoring.
- Exceptional Clinical Outcomes: High long-term success with low complication rates.
Unique Korean Innovations
- AI-guided implant angle and resistance prediction.
- Ultra-low-trauma subconjunctival tunneling techniques.
- Enhanced anti-fibrotic therapy for long-term flow stability.
- Hybrid approaches (Filtration MIGS + angle-based MIGS).
- Long-term bleb and implant health tracking using deep-learning analytics.
These advancements make Filtration MIGS in Korea one of the most effective, safe, and long-lasting solutions for patients needing significant IOP reduction without the invasiveness of traditional glaucoma surgery.
Cost Range (Indicative Estimate)
| Treatment Package | Price (KRW) | Approx. USD | Inclusions |
|---|---|---|---|
| Standard Filtration MIGS | ₩2,800,000 – ₩4,000,000 | ~$2,100 – $3,000 | Standard micro-stent implantation & follow-up |
| Premium OCT-Guided Filtration MIGS | ₩4,200,000 – ₩6,000,000 | ~$3,200 – $4,500 | OCT-guided placement, AI planning, anti-fibrotic therapy |
| Advanced Hybrid MIGS Program | ₩6,500,000 – ₩9,000,000+ | ~$4,900 – $6,800+ | Combined filtration + angle/suprachoroidal MIGS |
Pricing varies by clinic, technology, and surgeon expertise.
Popular Clinics in Korea
- B&VIIT Eye Center (Seoul): Leaders in filtration MIGS and micro-stent surgery.
- Dream Eye Center (Seoul): Known for OCT-guided subconjunctival MIGS precision.
- BGN Eye Clinic (Seoul & Busan): Experts in XEN, PreserFlo, and hybrid MIGS programs.
- Glory Seoul Eye Clinic: Specializes in controlled bleb formation and long-term stability.
- K-Cure Vision Center (Gangnam): AI-enhanced MIGS planning for filtration-based procedures.
